首页 > 市场调查报告书 > 消费品

健康美容化妆品

市场调查报告书

商品编码

1624888

活性成分市场：药品、农业化学品、个人护理品和化妆品（按地区划分），2024 年至 2031 年

Active Ingredients Market By Pharmaceuticals (Prescription Drugs, Over-the-Counter Drugs, Biological Products), Agrochemicals, Personal Care and Cosmetics, & Region for 2024-2031

出版日期: 2024年09月05日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年至 2031 年活性成分市场评估

对活性成分的需求不断增长，很大程度上是由于消费者对健康和保健产品的瞭解和偏好不断增加。活性成分是药品、化妆品、个人护理产品和其他健康相关商业产品的关键成分，在实现所需的治疗或美容效果方面发挥关键作用。随着人们健康意识的增强，对抗衰老、美白、增强免疫力等具有特殊功效的产品的需求将会增加，预计2024年销售额将超过28.3亿美元，2031年将达到41亿美元。值将达到5000万美元。

由于技术和科学的突破，活性成分市场正在扩大。生物技术、奈米技术和合成生物学的进步使得创造更有效的活性物质成为可能。例如，在皮肤护理中使用奈米技术可以提高活性化合物的吸收和功效。此外，製药业务也不断研究和开发新的活性成分，以满足尚未满足的医疗需求，例如治疗慢性病、癌症和精神健康问题。因此，2024 年至 2031 年期间市场将以 4.90% 的复合年增长率成长。

活性成分市场定义/概述

活性成分是使产品正常发挥作用的关键成分。对于药物而言，活性成分是直接治疗或控制疾病或症状的化学实体。例如，止痛药布洛芬中的活性成分有助于减轻疼痛和发炎。活性化学物质可区分一种产品与另一种产品，并决定其功能。

活性成分是指产品中能产生预期效果的物质，无论是药物、化妆品或农产品。在药物中，活性成分是提供治疗功效的主要成分。例如，就止痛药而言，活性成分可能是布洛芬，它可以减轻发炎和疼痛。这些化学物质经过精心挑选，以针对特定的症状和疾病，确保药物的有效性。

未来活性化合物在医药、化妆品和农业领域的应用可能会取得突破。有效成分是药物中发挥治疗作用的主要部分。随着生物技术和个人化医疗的进步，未来无疑将出现更多针对特定基因特征量身定制的活性成分。这意味着，如果治疗能够根据每个人的生物组成进行定制，治疗可能会更成功，副作用也更少。

在药品製造上的广泛使用是否会推动活性成分市场的发展？

活性成分在药品製造上的广泛使用是活性成分市场的主要驱动力。这一趋势是由人口增长、预期寿命延长和慢性病增加等因素所推动的，全球对药品的需求不断增加。根据世界卫生组织（WHO）的数据，2018年全球卫生支出为8.3兆美元，占全球GDP的10%。对医疗保健的大量投资增加了对药品及其活性成分的需求。

根据美国食品药物管理局（FDA）统计，2020年共有53种创新药物获得核准，彰显製药业的持续创新与成长。新型医药产品的不断开发对活性成分产业的成长产生直接影响。药品製造中活性成分的广泛使用是活性成分市场发展的主要驱动力。这一趋势是由人口增长、预期寿命延长和慢性病增加等因素所推动的，全球对药品的需求不断增加。根据世界卫生组织（WHO）的数据，2018年全球卫生支出为8.3兆美元，占全球GDP的10%。对医疗保健的大量投资增加了对药品及其活性成分的需求。根据美国食品药物管理局（FDA）统计，2020年共有53种创新药物获得核准，显示製药业持续创新成长。新药研发的推进对药物成分产业的成长有直接的影响。

监理限制是否阻碍了活性成分市场？

监管限制可能会成为活性成分市场的一个重大障碍，阻碍其成长和发展。特别是在製药和农业化学品行业，新的活性成分的严格审批流程构成了重大的监管障碍。根据美国食品药物管理局（FDA）的数据，处理新药申请的平均时间约为12个月，但一些更复杂的申请可能需要更长的时间。延长的时间可能会减慢创新产品的市场开发速度并增加公司的开发成本。

此外，欧洲药品管理局 (EMA) 报告称，新活性物质的平均评估时间约为 423 天，突显了主要市场的监管週转时间缓慢。另一个重要的监管限制是对环境和安全法规的日益重视。欧洲化学品管理局 (ECHA) 负责实施《化学品註册、评估、授权和限制》(REACH)，要求企业註册每年生产或进口数量超过一吨的任何化学物质。此外，美国环保署 (EPA) 报告称，2020 财年完成了超过 22,000 种农药产品审查，显示对农药业的监管十分严格。

The rising demand for active ingredients is largely due to increased customer knowledge and preference for health and wellness goods. Active ingredients which are critical components of medications, cosmetics, personal care products, and other health-related items play an important role in achieving the desired therapeutic or cosmetic outcome. As individuals grow more health-conscious, there is a greater demand for products that provide specialized benefits such as anti-aging, skin brightening, immune boosters, and other targeted impacts by enabling the market to surpass a revenue of USD 2.83 Billion valued in 2024 and reach a valuation of around USD 4.15 Billion by 2031.

The active ingredients market is expanding due to technological and scientific breakthroughs. Biotechnology, nanotechnology, and synthetic biology advancements have made it possible to create more potent and effective active substances. For example, using nanotechnology in skincare improves the absorption of active compounds, increasing their potency. Furthermore, the pharmaceutical business is always researching and developing novel active ingredients to meet unmet medical requirements such as therapies for chronic diseases, cancer, and mental health issues. This enables the market to grow at aCAGR of 4.90% from 2024 to 2031.

Active Ingredients Market: Definition/ Overview

Active ingredients are the key components of a product that allow it to work properly. In the case of pharmaceuticals, the active ingredient is a chemical component that directly treats or manages the symptoms of a disease or condition. For example, the active component in ibuprofen, a pain reliever is responsible for lowering pain and inflammation. Active chemicals distinguish one product from another and determine how it functions.

Active ingredients are substances in products that create the desired results whether in medications, cosmetics, or agricultural products. In medicines, active ingredients are the primary components that provide therapeutic advantages. For example, in pain relievers, the active ingredient may be ibuprofen which decreases inflammation and pain. These chemicals are carefully chosen to address specific symptoms or illnesses assuring the medication's efficacy.

The future usage of active compounds, notably in pharmaceuticals, cosmetics, and agriculture, is likely to be revolutionary as breakthroughs arise. Active ingredients are the primary components of medications that provide therapeutic effects. With advances in biotechnology and customized medicine, the future will most certainly see a trend toward more tailored active ingredients that cater to specific genetic profiles. This means that therapies may become more successful and have fewer negative effects if they are tailored to each individual's biological composition.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Extensive Use in Drug Manufacturing Drive the Active Ingredients Market?

The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018, accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and, by extension, active ingredients.

The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry. The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018 accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and by extension, active ingredients. The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry.

Will the Regulatory Constraints Hamper the Active Ingredients Market?

Regulatory limits present important obstacles for the active ingredients market, potentially impeding its growth and development. The demanding clearance process for new active ingredients, notably in the pharmaceutical and agrochemical industries is a significant regulatory barrier. According to the United States Food and Drug Administration (FDA), the average time for approving a new drug application is about 12 months with some complex applications taking considerably longer. This prolonged timeline may delay market introduction for innovative items and increase the company's development expenses.

Furthermore, the European Medicines Agency (EMA) reports that the average period for evaluating a new active substance is approximately 423 days highlighting the time-consuming nature of regulatory compliance in key markets. Another key regulatory restraint is an increased emphasis on environmental and safety regulations. The European Chemicals Agency (ECHA) enforces the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) law which requires enterprises to register chemical substances produced or imported in quantities of one tonne or more each year. Furthermore, the United States Environmental Protection Agency (EPA) reported completing over 22,000 pesticide product reviews in fiscal year 2020 indicating substantial regulatory monitoring in the agrochemical industry.

Category-Wise Acumens

Will a Wide Range of Serious and Chronic Medical Conditions Drive Growth in the Pharmaceutical Segment?

Prescription medications dominate because of their importance in treating a wide spectrum of serious and chronic medical disorders. Prescription medications contain active chemicals that have been precisely designed and approved for targeted therapies which are frequently used to treat complicated conditions such as cancer, cardiovascular difficulties, and autoimmune disorders. These active chemicals go through extensive research and clinical trials to confirm their efficacy and safety making them indispensable in modern medicine. The increased frequency of chronic diseases, an aging population, and ongoing innovation in medication development all contribute to prescription pharmaceutical supremacy.

Pharmaceutical companies invest extensively in research and development to generate new active components that can deliver more effective treatments with fewer side effects highlighting the importance of prescription pharmaceuticals. OTC medications and biological products play important roles in the market but they do not supplant prescription drugs. OTC medications while necessary for treating common and less severe illnesses, often contain well-established active components and do not require doctor supervision resulting in lower regulatory obstacles and research expenditure when compared to prescription drugs.

Will the Growing Consumer Awareness Drive the Personal Care and Cosmetics Segment?

Skincare goods segment is projected to dominate the market over the forecast period. This dominance is driven by increasing consumer awareness and concern about skin health, aging, and general skin look. Moisturizers, anti-aging creams, and treatments for acne and hyperpigmentation are becoming increasingly popular as customers prioritize preserving a young appearance and addressing specific skin ailments. The global increase in pollution, stress, and UV radiation has increased the demand for effective skincare solutions resulting in a spike in the discovery and application of new active ingredients.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers changing wants.

Country/Region-wise Acumens

Will the Rising Prevalence of Preventable Chronic Diseases Drive the Market in the North American Region?

The growing frequency of avoidable chronic diseases in North America is primarily driving the market for active ingredients. This tendency is especially noticeable in the United States which accounts for a sizable chunk of the industry. The increasing frequency of chronic diseases in North America is a significant driver of the active ingredients market. According to the Centers for Disease Control and Prevention (CDC), six out of ten persons in the United States have a chronic disease with four out of ten having two or more chronic disorders. These astonishing figures underline the critical need for improved treatments and prevention strategies.

Chronic diseases impose an equal economic impact with the National Center for Chronic Disease Prevention and Health Promotion claiming that people with chronic and mental health conditions account for 90% of the nation's $3.8 trillion in yearly health care costs. This significant economic impact highlights the significance of treating chronic diseases and increases demand for active ingredients in medicines and nutraceuticals. The active ingredients market is also being boosted by the increased awareness of preventive healthcare measures among North Americans. The Healthy People 2030 effort launched by the United States Department of Health and Human Services seeks to reduce the burden of preventable diseases by encouraging health and wellness.

Will the Rapid Urbanization and an Expanding Middle-Class Population Drive the Market in the Asia Pacific Region?

The Asia Pacific region is witnessing the world's fastest urbanization rate with China and India leading the way. This fast urbanization combined with a rapidly rising middle-class population is expected to be a big driver of the region's active ingredients market. Urbanization in Asia Pacific is accelerating at an unprecedented rate. According to the United Nations Department of Economic and Social Affairs, Asia's urban population is expected to grow from 2.2 billion in 2020 to 3.5 billion in 2050. China alone is estimated to add 255 million urban residents between 2020 and 2050. This tremendous change to urban living is accompanied by changing lifestyles, higher disposable incomes, and heightened knowledge of personal care and health products.

Competitive Landscape

The Active Ingredients Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the active ingredients market include:

BASF SE

The Dow Chemicals Company

Ashland, Inc.

Rhodia

Du Pont

Sumitomo Group

LOral S.A.

Beiersdorf AG

Sederma, Inc.

Evonik Industries

Latest Developments

In October 2020, Evonik significantly increased its bio-based line of active ingredients for the beauty and personal care industries in response to rising demand for innovative, sustainably sourced products.

In April 2021, Ashland announced a new active skin care component, claiming to enhance vibrancy and "glow" for a well-aged appearance.

1.Introduction

Market Definition
Market Segmentation
Research Methodology

2. Executive Summary

Key Findings
Market Overview
Market Highlights

3. Market Overview

Market Size and Growth Potential
Market Trends
Market Drivers
Market Restraints
Market Opportunities
Porter's Five Forces Analysis

4. Active Ingredients Market, By Pharmaceuticals

Prescription Drugs
Over-the-Counter (OTC) Drugs
Biological Products

5 Active Ingredients Market, By Agrochemicals

Herbicides
Insecticides
Fungicides
Plant Growth Regulators

6 Active Ingredients Market, By Personal Care and Cosmetics

Skin Care Products
Hair Care Products
Cosmetics

7. Regional Analysis

North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Asia-Pacific
China
Japan
India
Australia
Latin America
Brazil
Argentina
Chile
Middle East and Africa
South Africa
Saudi Arabia
UAE

8. Market Dynamics

Market Drivers
Market Restraints
Market Opportunities
Impact of COVID-19 on the Market

9. Competitive Landscape

Key Players
Market Share Analysis

10. Company Profiles

Pfizer
Merck & Co.
Roche
Novartis
Johnson & Johnson
BASF SE
Dow Chemical Company
Evonik Industries
Ashland Inc.
Clariant

11. Market Outlook and Opportunities

Emerging Technologies
Future Market Trends
Investment Opportunities

12. Appendix

List of Abbreviations
Sources and References

02-2729-4219

+886-2-2729-4219

License/价格

活性成分市场：药品、农业化学品、个人护理品和化妆品（按地区划分），2024 年至 2031 年